Goodwin Investment Advisory’s Vaxart VXRT Stock Holding History

Goodwin Investment Advisory’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$1K	–	148
2020 Q4	$1K	Buy	+200	New	+$1.27K	﹤0.01%	92

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Goodwin Investment Advisory's VXRT Position: Q1 2021 in Review

Goodwin Investment Advisory sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 200 shares — an estimated $1K sold.

Goodwin Investment Advisory first reported a position in VXRT in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

Goodwin Investment Advisory reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
Goodwin Investment Advisory sold 200 Vaxart shares in Q1 2021, an estimated $1K.
Goodwin Investment Advisory first reported a position in Vaxart in Q4 2020 and held it in 1 quarter.
Goodwin Investment Advisory's Vaxart position peaked at $1K in Q4 2020.
159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Goodwin Investment Advisory's 13F filing for Q1 2021, filed 5 May 2021.